These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6968594)

  • 1. Low-molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Biotechnol Bioeng; 1980; 22 Suppl 1():99-110. PubMed ID: 6968594
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight immunomodifiers produced by micro-organisms.
    Umezawa H
    Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Low molecular weight immunomodulators produced by microorganisms].
    Ishizuka M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
    Lin ZB; Shi JP
    Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):115-20. PubMed ID: 3892667
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation, characterization and biological evaluation of datura lactones as potential immunomodulators.
    Bhat BA; Dhar KL; Puri SC; Qurishi MA; Khajuria A; Gupta A; Qazi GN
    Bioorg Med Chem; 2005 Dec; 13(24):6672-7. PubMed ID: 16198115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enzyme inhibitors in inhibiting the growth and inducing the differentiation of human promyelocytic leukemia cells, HL-60.
    Miura K; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 May; 39(5):734-5. PubMed ID: 3460977
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
    Umezawa H
    Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight immunomodifiers produced by microorganisms.
    Umezawa H; Ishizuka M
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-molecular-weight immunocorrectors of natural origin].
    Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo actions of bestatin-related compounds in relation to their actions in vitro.
    Aoyagi T; Wada T; Ohuchi S; Kawamura K; Fukatsu S; Umezawa H
    Biochem Int; 1984 Nov; 9(5):643-50. PubMed ID: 6525200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
    Millership JJ; Didier ES; Okhuysen PC; Maddry JA; Kwong CD; Chen X; Snowden KF
    J Eukaryot Microbiol; 2001; Suppl():95S-98S. PubMed ID: 11906096
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
    Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
    J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-molecular weight immunomodulators of microbial origin].
    Khurnova LM; Ivanitskaia LP
    Antibiot Khimioter; 1989 Oct; 34(10):786-92. PubMed ID: 2694992
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.
    Lass C; Vocanson M; Wagner S; Schempp CM; Nicolas JF; Merfort I; Martin SF
    Exp Dermatol; 2008 Oct; 17(10):849-57. PubMed ID: 18341569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
    Bachelier A; Mayer R; Klein CD
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5605-9. PubMed ID: 16945528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of splenic enzyme activities by administration of aminopeptidase N (CD13) inhibitors: relationship between actions in vivo and in vitro.
    Kocha T; Ohtsuka E; Funahashi T; Fukuda T; Aoyagi T; Wanda T; Takeuchi T
    J Enzyme Inhib; 1994; 8(3):187-95. PubMed ID: 7539487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor delayed hypersensitivity reactions. "In vivo" functional differences between spleen and peripheral blood lymphocytes.
    de Bonaparte YP; Oisgold-Dagá S; Klein S; Stillitani-D'Elia I
    Biomedicine; 1980 Feb; 33(1):16-8. PubMed ID: 7370382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa.
    Máñez S; Hernández V; Giner RM; Ríos JL; Recio Mdel C
    Fitoterapia; 2007 Jun; 78(4):329-31. PubMed ID: 17490829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.